Outperform the ASX with CSL Limited and Ramsay Health Care Limited

These 2 stocks look set to beat the wider index: CSL Limited (ASX:CSL) and Ramsay Health Care Limited (ASX:RHC)

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For many investors, the health care sector is one of the best places to invest for the long term. That's at least partly because, historically, it has offered stunning returns and the opportunity to outperform the wider index.

Furthermore, the health care sector's financial performance is far less correlated with the wider economic outlook than most sectors and, as a result, the share prices of health care companies tend to help a portfolio to smooth out the peaks and troughs of the ASX's performance. In addition, health care stocks tend to have relatively low betas and this means that their volatility is also lower than the wider index, too.

Of course, health care stocks are understandably popular at the present time. The ASX has fallen by 9% in the last six months and, looking ahead, there could be more pain in the short run. That's especially the case since the Chinese economy is continuing to endure a soft landing and the falling price of commodities is having a knock-on effect on the Aussie economy.

As such, the share prices of health care stocks such as pharmaceutical company, CSL Limited (ASX: CSL), and private hospital operator, Ramsay Health Care Limited (ASX: RHC), have soared by 32% and 30% respectively in the last year. Looking ahead, they both have the scope to become even more popular among investors owing to them having betas of just 0.6 (CSL) and 0.5 (Ramsay). This means that for every 1% move in the value of the ASX, CSL and Ramsay's share prices should change by 0.6% and 0.5% respectively, thereby making them excellent defensive plays during a downturn.

In addition, growth prospects for the two companies are also strong, with CSL due to post a rise in earnings of 12.4% in each of the next two years and Ramsay being expected to increase its bottom line by 19.6% per annum during the same time period. Their low correlation with the wider Aussie economy is clearly a major pull for investors and, with the majority of CSL's earnings being derived from outside of the domestic economy and Ramsay also having operations in Europe and in Asia, they could both gain a real boost from the weakening Aussie dollar over the medium term.

Clearly, neither stock is dirt cheap, but their price to earnings growth (PEG) ratios indicate good value based on their prospects, stability and track records of growth. As a result, PEG ratios of 1.95 (CSL) and 1.58 (Ramsay) may be higher than the ASX's PEG ratio of 1.38 but the two health care stocks have managed to increase earnings at an annualised rate of 22% (CSL) and 21% (Ramsay) during the last 10 years, thereby making them much more reliable than the vast majority of ASX-listed companies.

So, while the ASX's performance over the medium term may be somewhat disappointing even if the RBA decides to cut interest rates further, CSL and Ramsay are likely to outperform it. As such, now seems to be an ideal time to buy a slice of both of them.

Motley Fool contributor Peter Stephens has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »